BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP, Barret JP. Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve. World J Dermatol 2017; 6(2): 32-41 [DOI: 10.5314/wjd.v6.i2.32]
URL: https://www.wjgnet.com/2218-6190/full/v6/i2/32.htm
Number Citing Articles
1
Ilaria Mataro, Anna Lanza, Sveva Di Franco, Livia Di Franco, Mariella Sangiuolo, Maria Notaro, Roberto d’Alessio, Romolo Villani. Releasing Burn-Induced Compartment Syndrome by Enzymatic Escharotomy-Debridement: A Case StudyJournal of Burn Care & Research 2020; 41(5): 1097 doi: 10.1093/jbcr/iraa055
2
Lior Rosenberg, Yaron Shoham, Stan Monstrey, Henk Hoeksema, Jeremy Goverman, William Hickerson, Ilaria Mataro, Adam J. Singer. Burn Care in the Era of Rapid Enzymatic Debridement: Challenging the Dogma that Healing Beyond 21 Days Results in Hypertrophic ScarringThe Open Dermatology Journal 2021; 15(1): 66 doi: 10.2174/1874372202115010066
3
Urška Jančič, Selestina Gorgieva. Bromelain and Nisin: The Natural Antimicrobials with High Potential in BiomedicinePharmaceutics 2021; 14(1): 76 doi: 10.3390/pharmaceutics14010076
4
Maximilian M. Mattern, Paul C. Fuchs, Jennifer L. Schiefer. Role, Development, and Value of Enzymatic Debridement as Integral Component in Initial Treatment of Burn Injuries Exemplified by NexoBrid®European Burn Journal 2022; 3(2): 340 doi: 10.3390/ebj3020029
5
Juan P. Barret, Julia Barret-Joly. Handbook of Burns Volume 12020; : 459 doi: 10.1007/978-3-030-18940-2_35